Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-08

Clinical Trial Update: A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rizatriptan for acute treatment of migraine in children and adolescents has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan (Rizatriptan)

Snippet

Sponsor: Organon and Co | Conditions: Migraine, Acute | Phase 3 | Status: COMPLETED | Results posted: 2012-05-08